|
2024
|
Invention
|
Photoswitchable compounds modulating cadherin homodimerization. Invention relates to photoswitcha... |
|
|
Invention
|
Macrocyclic tubulin polymerization inhibitors as anticancer agents. 5050 = 12–90 nM. |
|
|
Invention
|
A new class of aryl hydrocarbon receptor antagonists and their optimisation. The invention relate... |
|
|
Invention
|
Thermostable engineered enzyme. The invention relates to an engineered PETase enzyme comprises an... |
|
2023
|
Invention
|
3-(acylamidomethyl)phenylboronic acid derivatives as malarial serine protease inhibitors. Represe... |
|
|
Invention
|
Development of trimethyllysine hydroxylase (tmlh) inhibitors. The present invention relates to a ... |
|
|
Invention
|
2-amino-n-(benzo[d]thiazol-2-ylsulfonyl)-3-hydroxybutanamide derivatives acting as a threonyl-t-r... |
|
|
Invention
|
Benzo[b]selenophenes as novel selective estrogen receptor modulators. The present invention relat... |
|
2022
|
Invention
|
[1,2]selenazolo[2,3-a]pyridin-8-ium inhibitors of pyruvate kinase isoform m2. The present inventi... |
|
|
Invention
|
Light emitting electrochemical cell.
The present invention relates to multi-layered light emitti... |
|
|
Invention
|
Light emitting electrochemical cell. The present invention relates to multi-layered light emittin... |
|
|
Invention
|
Pyridinium light emitting molecules. The present invention relates to light emitting pyridinium s... |
|
|
Invention
|
Chemically modified engineered spider silk proteins. The present invention relates to recombinant... |
|
2021
|
Invention
|
Novel adenosylmercaptane derivatives as viral mrna cap methyltransferase inhibitors. The present ... |
|
|
Invention
|
2-(2-oxo-3-pyrolin-1-yl)acetamides as anticonvulsants. This invention relates to the preparation ... |
|
|
Invention
|
An assay for measuring binding affinity for cardiolipin of biologically active compounds.
The pr... |
|
|
Invention
|
An assay for measuring binding affinity for cardiolipin of biologically active compounds. The pre... |
|
|
Invention
|
Curcumin dihydropyridone derivatives with anti-cancer activity. The present invention includes DH... |
|
2020
|
Invention
|
Fluorescent acridinium salts, synthesis thereof and use for detection of cardiolipin.
The presen... |
|
|
Invention
|
Fluorescent acridinium salts, synthesis thereof and use for detection of cardiolipin. The present... |
|
|
Invention
|
Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents... |
|
|
Invention
|
Novel boronic acid containing peptidomimetics as malarial serine protease inhibitors. The inventi... |
|
|
Invention
|
Selenophenochromene phosphonic acids, preparation and use as antiproliferative agents. The presen... |
|
2019
|
Invention
|
Structurally simplified diazonamide analogs as antimitotic agents. The present invention relates ... |
|
|
Invention
|
Macrocyclic amides acting as plasmepsin inhbitors for the treatment of malaria. The present inven... |
|
|
Invention
|
Derivatives of aziridine-2-carboxamide as inhibitors of thioredoxin reductase, their synthesis, a... |
|
|
Invention
|
New metal-organic frameworks and their use for encapsulation of fluorescent dyes. Disclosed are n... |
|
2018
|
Invention
|
Selenophenochromene hydroxamic acids, preparation and use as angiogenesis inhibitors. The present... |
|
|
Invention
|
1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in cancer treatment. The invention relates to ... |
|
2016
|
Invention
|
Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. Use ... |
|
|
Invention
|
Antimetastatic 2h-selenopheno[3,2-h]chromenes, synthesis thereof, and methods of using same agent... |
|
2015
|
Invention
|
A method for preparation of ibrutinib precursor. A method for the preparation of ibrutinib's prec... |
|
|
Invention
|
Substituted aminoalkylazoles as malarial aspartic protease inhibitors. The present invention rela... |
|
|
Invention
|
Ethynylxanthines, preparation and use for cancer treatment. The present invention relates to nove... |
|
|
Invention
|
Ethynylxanthines, preparation and use as calcium ion channel modulators. The present invention re... |
|
|
Invention
|
Novel ethynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and ... |
|
2014
|
Invention
|
Pharmaceutical composition for controlling body mass gain comprising s-phenotropil.
The inventio... |
|
|
Invention
|
Pharmaceutical composition for controlling body mass gain comprising s-phenotropil. The invention... |
|
|
Invention
|
A method for preparation of erlotinib. A method for the preparation N-(3-ethynylphenyl)-6,7-bis(2... |
|
2013
|
Invention
|
Hydridopalladium(ii) halides as preformed catalysts for suzuki-miyaura cross-coupling reactions. ... |
|
|
Invention
|
Novel substituted 2-aminoquinazolin-4(3h)-one derivatives as malarial aspartic protease inhibitor... |
|
|
Invention
|
"pharmaceutical composition for reducing the trimethylamine n-oxide level".
The invention disclo... |
|
|
Invention
|
Pharmaceutical composition for reducing the trimethylamine n-oxide level. The invention discloses... |
|
|
Invention
|
Thieno [2,3-b] pyridines as multidrug resistance modulators. The thieno[2,3-b]pyridines of genera... |
|
|
Invention
|
Thieno[2,3-b]pyridines as multidrug resistance modulators. The thieno[2,3-b]pyridines of general ... |
|
2010
|
Invention
|
S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. Th... |
